BMC in collaboration with her Sister Institution-CUHAS have created a range of research opportunities in HIV, Malaria, TB, Schostomiasis, Cancers and Cardiovascular Diseases. The two sister instutions have a joint Instutional Review Board and have a research Policy.
BMC has a Directorate of research and has a conducive environment for both local and international collaborations. BMC has a diverse of clinicians experienced in research, managing research grants/projects, supervising postgraduate/elective students/ fellows and houses an accredited Laboratory which performs molecular studies. Local partners include the National Institute of Medical Research and Ifakara Research Institute while international collaborators are; Germany (Medical Mission Institute and Wurzburg University), South Africa (Stellenbosch University) and US (Duke University and Weill Cornell University).

---

Some of the ongoing research projects includes:

• Global Congestive Heart Failure (G‐CHF); a global registry to study the demographics, socioeconomic and clinical factors, etiologies, pathophysiology, management, barriers to care, and outcomes of heart failure patients. (Makubi A & Salim Yusuph et al).
• HIV and Pulmonary Hypertension (Perk et al)
• Outcomes of adults patients with heart failure attending referral hospitals in Mwanza City-MEPI (Wajanga B et al)
• Implementing Strategies for Breast Cancer Control in Africa (Masalu N et al)
• Developing Capacity for Pediatric Cancer Clinical Research in Tanzania (Masalu N et al)
• HIV in the elderly- hypertension and diabetes mellitus prevalence and organizational readiness for care integration in HIV clinics- (Wemael et al)
• Clinical and Pathological Pattern of Peripheral Lymphadenopathy in HIV-Infected Patient in Northern Tanzania (Schroede et al)
• HPV Vaccine Therapy in reducing high grade cervical lesions in patients with HIV and HPV (COVENANT); a phase 3 RCT (Albert et al)
• Sickle cell gene mapping- in collaboration with Cincinati Children’s Hospital (Hokororo et al)
• The Impacts of HIV drug resistance testing, and subsequent change to individualized therapy based on the resistance profile in children, adolescents and adults with virological failure of their HIV therapy, in three HIV clinics in Tanzania (Shimba et al)

• Longitudinal Quality of Life Study Among Participants with AID-Associated Kapos Sarcoma at Bugando Medical Centre
  This is a project for AID Malignancy Consortium (AMC) who are in collaboration with Bugando Medical Centre (BMC), AMC is a National Cancer Institute-supported clinical trial group founded in 1995 to support innovative trials for AIDS-related cancers.
  The AMC mission is to investigate new treatment and prevention interventions for malignancies in people living with HIV and to study the pathobiology of these tumors in the context of clinical trials.
  The goal of this project is to evaluate the longitudinal quality of life of participants with HIV-associated KS during treatment with vincristine and bleomycin at single institution in East Africa.

• Clinical and pattern of peripheral lymphadenopathy in HIV-infected patients in Northern Tanzania
  This is the project under Duke University Global Cancer Program who are jointly supported by the Duke Cancer Institute (DCI) and the Duke Global Health Institute(DGHI),
  the program has partnered with three international sites to assist with capacity-building in care and research; the Bugando Medical Centre in Mwanza Tanzania, the Tata Medical Centre in Kolkata India, and the Barretos Cancer Hospital in Brazil. Bugando Medical Cancer Centre is an important partner as evidenced by the placement of a full-time faculty member on-site, Dr.Kristin Schroeder.
  The goal of this project is to better understand the clinical and pathological pattern of peripheral lymphadenopathy of HIV-infected patients in northern Tanzania.

• Developing Capacity for Pediatric Cancer Clinical Research in Tanzania
  This project is also under Duke University Global Cancer Program. Duke Global Health Institute (DGHI) and Duke Cancer Institute (DCI) launched the Duke Global Cancer Program to expand cancer care, prevention, research, and education in low-and middle –income countries. Establishing a global cancer research initiative serves to consolidate and build upon ongoing efforts by Duke Faculty and trainees interested in contributing to best practices in clinical care, institutional support for capacity-building, and disseminating innovation in global cancer.
  • The goal of this project is the development of a clinical database to evaluate treatment response and outcomes for patients with pediatric cancer at Bugando Medical Centre.
  • To assess the feasibility of next generation sequencing of solid tumor samples from Tanzania.

• Time to Act: Implementation Strategies for Breast-Cancer Control in Africa
  Johns Hopkins Bloomberg School of Public Health is in collaboration with Bugando Medical Centre (BMC)
  The goal of this project is to assess multi-level contextual factors affecting successful implementation of breast cancer control program in Mwanza, Tanzania.

• Creating Awareness of childhood Cancer .A Tanzania Grassroots Approach
  The goal of this project is to improve diagnosis rates of pediatric cancer in Tanzania in order to increase access to treatment.